P

Perceptive Advisors portfolio

Perceptive Advisors has 5 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months. It led 3 of the 5 rounds it joined. Its most recent investment on record is Talkiatry's $210M Series B+ round in February 2026, which it led, alongside Sofina, Left Lane Capital, Blisce and 1 other. By category, its portfolio leans toward Health and bio (5) and Insurance (1). It has co-invested with Andreessen Horowitz, Sofina and Left Lane Capital, most often Andreessen Horowitz (2 rounds).

What Perceptive Advisors invests in

• Health and bio · 5 · 100%
• Insurance · 1 · 20%
• Consumer and social · 1 · 20%
• Developer tools and cloud · 1 · 20%
• Manufacturing and industrial · 1 · 20%

Perceptive Advisors recent investments

Company	Round	Date	Alongside
TTalkiatry	Series B+ · $210M · lead	Feb 12, 2026	Sofina, Left Lane Capital, Blisce +1
MMerida Biosciences	Series A · $120M	May 7, 2025	Third Rock Ventures (lead), GV, Biotechnology Value Fund (lead) +1
KKardigan	Series A · $300M · lead	Jan 1, 2025	Sequoia Heritage (lead), ARCH Venture Partners (lead)
TTalkiatry	Series B+ · $130M	Jun 18, 2024	Andreessen Horowitz (lead)
SSynthego	Series B+ · $200M · lead	Feb 17, 2022	Wellington Management, SoftBank Vision Fund, RA Capital Management +6

How Perceptive Advisors invests

Share is of the 5 rounds on Recent Funding that name Perceptive Advisors. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Perceptive Advisors portfolio companies

• TTalkiatry$210MSeries B+ · Feb 2026
• MMerida Biosciences$120MSeries A · May 2025
• KKardigan$300MSeries A · Jan 2025
• SSynthego$200MSeries B+ · Feb 2022
• AAvalyn Pharmabacker

Company	Round with Perceptive Advisors	Total raised	Latest raise
TTalkiatry Insurance	Feb 12, 2026 Series B+ · $210M · lead	$360M	Feb 12, 2026 Series B+
MMerida Biosciences Health and bio	May 7, 2025 Series A · $120M	$120M	May 7, 2025 Series A
KKardigan Health and bio	Jan 1, 2025 Series A · $300M · lead	$550M	Oct 15, 2025 Series B+
SSynthego Health and bio	Feb 17, 2022 Series B+ · $200M · lead	$459M	Feb 17, 2022 Series B+
AAvalyn Pharma Health and bio	backer	$135.5M	Sep 27, 2023 Series B+

Most frequent co-investors

• AAndreessen Horowitz2 shared rounds · last Feb 12, 2026
• SSofina1 shared round · last Feb 12, 2026
• LLeft Lane Capital1 shared round · last Feb 12, 2026
• BBlisce1 shared round · last Feb 12, 2026
• GGV1 shared round · last May 7, 2025
• BBain Capital Life Sciences1 shared round · last May 7, 2025
• TThird Rock Ventures1 shared round · last May 7, 2025
• BBiotechnology Value Fund1 shared round · last May 7, 2025
• AARCH Venture Partners1 shared round · last Jan 1, 2025
• SSequoia Heritage1 shared round · last Jan 1, 2025
• WWellington Management1 shared round · last Feb 17, 2022
• SSoftBank Vision Fund1 shared round · last Feb 17, 2022

Similar investors

• DDecheng Capital5 companies · 3 deals in 12 mo
• MMaverick Ventures5 companies · 3 deals in 12 mo
• MMMC Ventures5 companies · 3 deals in 12 mo
• RRegeneron Ventures5 companies · 3 deals in 12 mo
• TThe Venture Collective5 companies · 3 deals in 12 mo
• BBlack Opal Ventures5 companies · 2 deals in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Perceptive Advisors, which is a subset of its real portfolio. API: /api/v1/investors/perceptive-advisors (get a free API key). More: the most active VC firms and new venture capital funds.